메뉴 건너뛰기




Volumn 124, Issue 7, 2014, Pages 991-992

A common progenitor cell in LCH and ECD

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; VEMURAFENIB; BRAF PROTEIN, HUMAN;

EID: 84905964723     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-06-581736     Document Type: Note
Times cited : (13)

References (8)
  • 1
    • 84905992289 scopus 로고    scopus 로고
    • Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation
    • Hervier B, Haroche J, Arnaud L, et al. Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation. Blood. 2014;124(7):1119-1126.
    • (2014) Blood , vol.124 , Issue.7 , pp. 1119-1126
    • Hervier, B.1    Haroche, J.2    Arnaud, L.3
  • 2
    • 77956904045 scopus 로고    scopus 로고
    • Recurrent BRAF mutations in Langerhans cell histiocytosis
    • Badalian-Very G, Vergilio JA, Degar BA, et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010;116(11):1919-1923.
    • (2010) Blood , vol.116 , Issue.11 , pp. 1919-1923
    • Badalian-Very, G.1    Vergilio, J.A.2    Degar, B.A.3
  • 3
    • 84866596727 scopus 로고    scopus 로고
    • High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses
    • Haroche J, Charlotte F, Arnaud L, et al. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012;120(13):2700-2703.
    • (2012) Blood , vol.120 , Issue.13 , pp. 2700-2703
    • Haroche, J.1    Charlotte, F.2    Arnaud, L.3
  • 4
    • 84876498502 scopus 로고    scopus 로고
    • Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation
    • Haroche J, Cohen-Aubart F, Emile JF, et al. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood. 2013;121(9):1495-1500.
    • (2013) Blood , vol.121 , Issue.9 , pp. 1495-1500
    • Haroche, J.1    Cohen-Aubart, F.2    Emile, J.F.3
  • 5
    • 84897944839 scopus 로고    scopus 로고
    • BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups
    • Berres ML, Lim KP, Peters T, et al. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med. 2014;211(4):669-683.
    • (2014) J Exp Med , vol.211 , Issue.4 , pp. 669-683
    • Berres, M.L.1    Lim, K.P.2    Peters, T.3
  • 7
    • 77952765452 scopus 로고    scopus 로고
    • Cell specific gene expression in Langerhans cell histiocytosis reveals a distinct profile compared to epithermal Langerhans cells
    • Allen CE, Li L, Peters TL, et al. Cell specific gene expression in Langerhans cell histiocytosis reveals a distinct profile compared to epithermal Langerhans cells. J Immunol. 2010;184(8):4557-4567.
    • (2010) J Immunol , vol.184 , Issue.8 , pp. 4557-4567
    • Allen, C.E.1    Li, L.2    Peters, T.L.3
  • 8
    • 76249095169 scopus 로고    scopus 로고
    • Development of monocytes, macrophages, and dendritic cells
    • Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science. 2010;327(5966):656-661.
    • (2010) Science , vol.327 , Issue.5966 , pp. 656-661
    • Geissmann, F.1    Manz, M.G.2    Jung, S.3    Sieweke, M.H.4    Merad, M.5    Ley, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.